铁烯胺衍生物作为小分子铁酶抑制剂的新型类别
Nastaran Ghasemi1, Shahram Moradi1, Aida Iraji2,3
1Faculty of Chemistry, Tehran North Branch, Islamic Azad University, Tehran, Iran.
BMC chemistry
|November 20, 2023
概括
新的 thiazolopyrimidine 衍生物被合成为强效的铁酶抑制剂,用于过色素化. 化合物6a显示出显著的抑制活性,为皮肤疾病治疗提供了有前途的途径.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 皮肤病学 皮肤病学
背景情况:
- 铁酶是黑色素发生的关键酶,直接影响着多颜色.
- 开发有效的铁酶抑制剂对于管理皮肤色素变质障碍至关重要.
研究的目的:
- 设计,合成和评估一系列新型的提亚佐洛皮里米丁衍生物作为铁酶抑制剂.
- 为了确定强效的化合物用于治疗多发色素.
主要方法:
- 使用FTIR,质量,1H-NMR和13C-NMR合成和对 thiazolopyrimidine 衍生物的结构性表征.
- 在体外评估铁酶抑制活性和IC50值的确定.
- 动力学研究,UV/Vis光谱学,分子对接和分子动力学模拟以阐明抑制机制.
主要成果:
- 一个新型类型的 thiazolopyrimidine 衍生物成功合成和表征.
- 化合物6a表现出最高的铁酶抑制功效,IC50值为28.50微米.
- 动力和光谱分析,以及分子建模,为6a化合物的抑制机制提供了洞察力.
结论:
- 合成的 thiazolopyrimidine 衍生物代表了一类有前途的铁酶抑制剂.
- 化合物6a是一种强有力的抑制剂,具有明确的作用机制,表明其在超色素化方面具有潜在的治疗应用.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K